A Unique E4/E5 Insertion Mutation of ABL Kinase in a BCR ABL (+) Patient

被引：0
|
作者：
Leonard, G. [1 ]
Rempfer, C. [1 ]
Pertain, J. [1 ]
Press, R. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2010年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：869 / 869
页数：1
相关论文
共 50 条
  • [21] Expression of the human papillomavirus type 11 E5A protein from the E1∧E4,E5 transcript
    Brown, DR
    McClowry, TL
    Sidner, RA
    Fife, KH
    Bryan, JT
    INTERVIROLOGY, 1998, 41 (01) : 47 - 54
  • [22] A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia
    Branford, S
    Rudzki, Z
    Hughes, TP
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (03) : 635 - 637
  • [23] HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers
    Ren, Shuling
    Gaykalova, Daria A.
    Guo, Theresa
    Favorov, Alexander, V
    Fertig, Elana J.
    Tamayo, Pablo
    Callejas-Valera, Juan Luis
    Allevato, Mike
    Gilardi, Mara
    Santos, Jessica
    Fukusumi, Takahito
    Sakai, Akihiro
    Ando, Mizuo
    Sadat, Sayed
    Liu, Chao
    Xu, Guorong
    Fisch, Kathleen M.
    Wang, Zhiyong
    Molinolo, Alfredo A.
    Gutkind, J. Silvio
    Ideker, Trey
    Koch, Wayne M.
    Califano, Joseph A.
    ONCOGENE, 2020, 39 (40) : 6327 - 6339
  • [24] HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers
    Shuling Ren
    Daria A. Gaykalova
    Theresa Guo
    Alexander V. Favorov
    Elana J. Fertig
    Pablo Tamayo
    Juan Luis Callejas-Valera
    Mike Allevato
    Mara Gilardi
    Jessica Santos
    Takahito Fukusumi
    Akihiro Sakai
    Mizuo Ando
    Sayed Sadat
    Chao Liu
    Guorong Xu
    Kathleen M. Fisch
    Zhiyong Wang
    Alfredo A. Molinolo
    J. Silvio Gutkind
    Trey Ideker
    Wayne M. Koch
    Joseph A. Califano
    Oncogene, 2020, 39 : 6327 - 6339
  • [25] Cyclotheonamide E4 and E5, new potent tryptase inhibitors from an Ircinia species of sponge
    Murakami, Y
    Takei, M
    Shindo, K
    Kitazume, C
    Tanaka, J
    Higa, T
    Fukamachi, H
    JOURNAL OF NATURAL PRODUCTS, 2002, 65 (03): : 259 - 261
  • [26] BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis
    B Schultheis
    L Wang
    R E Clark
    J V Melo
    Leukemia, 2003, 17 : 2054 - 2055
  • [27] BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis
    Schultheis, B
    Wang, L
    Clark, RE
    Melo, JV
    LEUKEMIA, 2003, 17 (10) : 2054 - 2055
  • [28] An intron-derived insertion/truncation mutation in the BCR-ABL kinase domain in three CML patients undergoing kinase inhibitor therapy
    Laudadio, Jennifer
    Deininger, Michael W. N.
    Mauro, Michael J.
    Druker, Brian J.
    Press, Richard D.
    BLOOD, 2007, 110 (11) : 581A - 581A
  • [29] Detection and Clinical Implications of a Novel BCR-ABL1 E12A2 Insertion/Deletion in a CML Patient Expressing the E13A2 Isoform
    Stella, Stefania
    Massimino, Michele
    Tirro, Elena
    Vitale, Silvia Rita
    Accurso, Vincenzo
    Puma, Adriana
    Pennisi, Maria Stella
    Di Gregorio, Sandra
    Romano, Chiara
    Di Raimondo, Francesco
    Siragusa, Sergio
    Manzella, Livia
    ANTICANCER RESEARCH, 2019, 39 (12) : 6965 - 6971
  • [30] Y253H mutation appearing in a μ-BCR-ABL (e19a2) CML
    Popovici, Cornel
    Charbonnier, Aude
    Gisserot, Olivier
    Aguilon, Philippe
    Remy, Virginie
    Olschwang, Sylviane
    Mozziconacci, Marie-Joelle
    LEUKEMIA RESEARCH, 2008, 32 (02) : 361 - 362
12345